BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 22968508)

  • 1. [The kidney transplantation from the ABO-incompatible donors].
    Goriaĭnov VA; Kaabak MM; Babenko NN; Shishlo LA; Morozova MM; Ragimov AA; Dashkova NG; Salimov ÉL
    Khirurgiia (Mosk); 2012; (7):70-4. PubMed ID: 22968508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kidney allotransplantation from the AB0-incompatible donors].
    Goriaĭnov VA; Kaabak MM; Babenko NN; Shishlo LA; Morozova MM; Ragimov AA; Dazhkova NG; Salimov EL
    Khirurgiia (Mosk); 2013; (12):67-72. PubMed ID: 24362296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excellent outcomes of ABO-incompatible kidney transplantation: a single-center experience.
    Uchida J; Kuwabara N; Machida Y; Iwai T; Naganuma T; Kumada N; Nakatani T
    Transplant Proc; 2012 Jan; 44(1):204-9. PubMed ID: 22310615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of pediatric ABO-incompatible kidney transplantations are equivalent to ABO-compatible controls.
    Shishido S; Hyodo YY; Aoki Y; Takasu J; Kawamura T; Sakai KK; Aikawa AA; Satou H; Muramatsu MM; Matsui Z
    Transplant Proc; 2012 Jan; 44(1):214-6. PubMed ID: 22310617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present status of ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Saito K
    Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO-incompatible kidney transplantation: first cases in Turkey.
    Tuncer M; Yücetin L; Tekin S; Demirbas A
    Transplant Proc; 2012; 44(6):1703-5. PubMed ID: 22841248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
    Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
    Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S; Hwang E; Park S; Park U; Kim H; Cho W
    Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABO-incompatibility in solid organ transplantation.
    Rydberg L
    Transfus Med; 2001 Aug; 11(4):325-42. PubMed ID: 11532188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO-incompatible kidney transplantation.
    Takahashi K; Saito K
    Transplant Rev (Orlando); 2013 Jan; 27(1):1-8. PubMed ID: 22902167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of ABO-incompatible living unrelated donor kidney transplantation.
    Uchida J; Machida Y; Iwai T; Kuwabara N; Iguchi T; Naganuma T; Kumada N; Kawashima H; Nakatani T
    Urol Int; 2011; 86(3):307-14. PubMed ID: 21358172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
    Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N
    Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO-incompatible kidney transplantation: long-term outcomes.
    Tanabe K; Ishida H; Inui M; Okumi M; Shirakawa H; Shimizu T; Omoto K; Kondo T
    Clin Transpl; 2013; ():307-12. PubMed ID: 25095522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation.
    Schwartz J; Stegall MD; Kremers WK; Gloor J
    Transplantation; 2006 Jul; 82(2):155-63. PubMed ID: 16858274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Takahara S; Uchida K; Yoshimura N; Toma H; Oshima S; Sonoda T;
    Transplant Proc; 2005 May; 37(4):1800-3. PubMed ID: 15919471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight years of outcomes of the Dutch Living Donor Kidney Exchange Program.
    de Klerk M; Kal-van Gestel JA; Haase-Kromwijk BJ; Claas FH; Weimar W;
    Clin Transpl; 2011; ():287-90. PubMed ID: 22755421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utilization and advantages of an exchange donor program in living donor renal transplantation: a single-center experience.
    Kim HS; Kwon OJ; Kang CM
    Transplant Proc; 2012 Jan; 44(1):14-6. PubMed ID: 22310566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
    Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation.
    Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Teraoka S; Toma H
    Transplant Proc; 2004 Sep; 36(7):2172-4. PubMed ID: 15518790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
    Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.